Literature DB >> 24381427

A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease.

Sandhya Mishra1, Dharamveer Yadav1, Monika Gupta2, Hemant Mishra3, Praveen Sharma4.   

Abstract

Non-alcoholic fatty liver disease shares many features of metabolic syndrome and its presence could signify a substantial cardiovascular risk above and beyond that conferred by individual risk factors. This study is an attempt to investigate the association of non-alcoholic fatty liver disease with carotid intima-media thickness and plaque as surrogate measures of increased cardiovascular risk. The study was conducted on 645 non diabetic, non alcoholic subjects in the age range of 20-60 years. Metabolic syndrome was assessed by using ATP III and ADA (2005) criteria. Anthropometric factors-waist circumference and blood pressure were measured. Fasting serum samples were analyzed for glucose, triglyceride, cholesterol and its fractions, insulin, alanine and aspartate transaminases, gamma glutamyl transferase and free fatty acids. Insulin resistance and secretion were calculated by homeostasis model and insulin sensitivity by QUICKI index. Liver ultrasonographic scanning was used for assessing fatty liver. Carotid atherosclerosis was assessed by B-mode ultrasonography of common carotid artery and internal carotid artery. The prevalence of non-alcoholic fatty liver disease was 15.6 % in non alcoholic population and 68.5 % of non-alcoholic fatty liver disease had metabolic syndrome, which was associated with hyperinsulinemia, insulin resistance, insulin insensitivity along with elevated levels of waist circumference, blood pressure, triglyceride, FFA and decreased HDL cholesterol. NAFLD patients had markedly greater carotid intima media thickness than non NAFLD subjects with MCIMT of 591.6 ± 108 and 489.5 ± 132.4 μm (P < 0.001) and plaque prevalence of 19.2 and 2.2 %, respectively, thus the carotid intima media thickness is associated with NAFLD.

Entities:  

Keywords:  CIMT; Carotid atherosclerosis; Metabolic syndrome; NAFLD

Year:  2012        PMID: 24381427      PMCID: PMC3547443          DOI: 10.1007/s12291-012-0286-8

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  38 in total

Review 1.  Nonalcoholic fatty liver disease: an agenda for clinical research.

Authors:  Zobair M Younossi; Anna Mae Diehl; Janus P Ong
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

2.  Enzymatic microdetermination of serum free fatty acids.

Authors:  S Shimizu; K Inoue; Y Tani; H Yamada
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

3.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Normal value of carotid intima-media thickness--a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound.

Authors:  Tiong K Lim; Eric Lim; Girish Dwivedi; Jaspal Kooner; Roxy Senior
Journal:  J Am Soc Echocardiogr       Date:  2007-08-30       Impact factor: 5.251

7.  Non-alcoholic steatohepatitis in type 2 diabetes mellitus.

Authors:  Parijat Gupte; Deepak Amarapurkar; Subhash Agal; Rajiv Baijal; Pramod Kulshrestha; Snehansu Pramanik; Nikhil Patel; Aruna Madan; Anjali Amarapurkar
Journal:  J Gastroenterol Hepatol       Date:  2004-08       Impact factor: 4.029

8.  Enzyme immunoassay for intact human insulin in serum or plasma.

Authors:  L Andersen; B Dinesen; P N Jørgensen; F Poulsen; M E Røder
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

9.  Oxidative stress in metabolic syndrome.

Authors:  Praveen Sharma; Sandhya Mishra; Peeyush Ajmera; Sandeep Mathur
Journal:  Indian J Clin Biochem       Date:  2005-01

10.  Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study.

Authors:  A Iglesias del Sol; M L Bots; D E Grobbee; A Hofman; J C M Witteman
Journal:  Eur Heart J       Date:  2002-06       Impact factor: 29.983

View more
  8 in total

1.  Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis.

Authors:  Jia Cai; Shujun Zhang; Wenxiang Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.

Authors:  Anshuman Elhence; Bhavik Bansal; Hardik Gupta; Abhinav Anand; Thakur P Singh; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-11-25

3.  Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.

Authors:  Ansel Shao Pin Tang; Kai En Chan; Jingxuan Quek; Jieling Xiao; Phoebe Tay; Margaret Teng; Keng Siang Lee; Snow Yunni Lin; May Zin Myint; Benjamin Tan; Vijay K Sharma; Darren Jun Hao Tan; Wen Hui Lim; Apichat Kaewdech; Daniel Huang; Nicholas Ws Chew; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah; Cheng Han Ng
Journal:  Clin Mol Hepatol       Date:  2022-03-02

4.  Causes of Thickening of Carotid Intima-Media Thickness in Patients With Alcoholic Liver Disease: A Prospective Observational Study.

Authors:  Bao-Ge Qu; Hui Wang; Yuan-Xun Liu; Yi-Guo Jia; Ji-Liang Su; Zhong-Dong Wang; Ya-Fei Wang; Xing-Hai Han; Jin-Dun Pan
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  The Correlation and Risk Factors between Carotid Intima-Media Thickening and Alcoholic Liver Disease Coupled with Helicobacter pylori Infection.

Authors:  Qu Bao-Ge; Wang Hui; Jia Yi-Guo; Su Ji-Liang; Wang Zhong-Dong; Wang Ya-Fei; Han Xing-Hai; Liu Yuan-Xun; Pan Jin-Dun; Ren Guang-Ying
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

Review 6.  Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.

Authors:  Abdulrahman Ismaiel; Dan L Dumitraşcu
Journal:  Front Med (Lausanne)       Date:  2019-09-13

7.  Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis.

Authors:  Mark Yu Zheng Wong; Jonathan Jiunn Liang Yap; Rehena Sultana; Mark Cheah; George Boon Bee Goh; Khung Keong Yeo
Journal:  Open Heart       Date:  2021-12

Review 8.  Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.

Authors:  Xin Xu; Linlin Lu; Quanyong Dong; Xiaolin Li; Nannan Zhang; Yongning Xin; Shiying Xuan
Journal:  Lipids Health Dis       Date:  2015-12-03       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.